Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
TesoRx Pharma, LLC logo — company profile

TesoRx Pharma, LLC

Founded 2010 United States Menlo Park, United States 3 employees Angel Biotechnology, Health Care +1

General Information

Company Name TesoRx Pharma, LLC
Founded Year 2010
Location United States Menlo Park, United States +1
Founders / Decision Makers
Ramachandran R. Thirucote — Founder and Chief Executive Officer
Employees 3
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Angel
Social

Get notified when TesoRx Pharma, LLC moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About TesoRx Pharma, LLC

TesoRx Pharma, LLC is a privately held pharmaceutical company focused on developing a first-in-class unmodified oral testosterone for androgen deficiency. The company has made significant progress, with phase two clinical study completion and plans to commence phase three dosing by early 2014. The US market for topical, transdermal, and injectable testosterone formulations is currently estimated at $2.1 billion, showing a 90% growth in prescriptions over five years. Analysts project the entire testosterone market to reach $5 billion by 2017. The main unmet need in the market is a safe and effective oral treatment regimen, with studies suggesting that it could potentially cannibalize over 70% of existing treatments once introduced. TesoRx Pharma operates within the biotechnology, health care, and health and wellness industries and is headquartered in the United States. The company's last investment, an angel investment, occurred on 12 November 2014. Although specific details about the investors involved in this round are not provided, TesoRx Pharma's pioneering approach to addressing a significant market need and its progress in clinical studies make it a compelling prospect for potential venture capital investment.

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Unknown - 12 Nov 2014
Series B Unknown - 05 Aug 2014
Venture - Series Unknown Unknown - 15 May 2014
Venture - Series Unknown Unknown - 30 Jul 2013
Venture - Series Unknown Unknown - 16 Jul 2012

View All 6 Funding Rounds

TesoRx Pharma, LLC Alternatives & Competitors

TesoRx Pharma, LLC vs
BioSante Pharmaceuticals
BioSante Pharmaceuticals

Pioneering advancements in female sexual health, menopause, contraception, and male hypogonadism wit...

Post Ipo Equity
Biotechnology, Health Care
TesoRx Pharma, LLC vs
Trimel Pharmaceuticals
Trimel Pharmaceuticals

Pioneering innovative solutions for male hypogonadism, female sexual dysfunction, and respiratory di...

Post Ipo Equity
Biotechnology, Health Care
TesoRx Pharma, LLC vs
ARSTAT Pharmaceuticals Inc.
ARSTAT Pharmaceuticals Inc. United States

Advancing transformational products for tens of millions of women

6 employees

FAQ About TesoRx Pharma, LLC

TesoRx is a privately held pharmaceutical company developing a first-in-class unmodified oral testosterone for androgen deficiency. It is in the process of completing a phase two clinical study and is on track to commence dosing for phase three by early 2014. The US market for topical, transderma...
TesoRx Pharma, LLC was founded in 2010.
TesoRx Pharma, LLC is headquartered in Menlo Park, United States.
TesoRx Pharma, LLC operates in the following industries: Biotechnology, Health Care, Health and Wellness.
TesoRx Pharma, LLC has approximately 3 employees.
TesoRx Pharma, LLC has completed 6 funding rounds. The latest funding stage is Angel.
Top alternatives and competitors to TesoRx Pharma, LLC include BioSante Pharmaceuticals, Trimel Pharmaceuticals, ARSTAT Pharmaceuticals Inc., MethylGene, Entera Bio Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TesoRx Pharma, LLC and BioSante Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors TesoRx Pharma, LLC and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy